View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
March 28, 2010

Young Women at Similar Risk from Cervical Disease, Says FDA

Women aged 16–20 are just as likely to develop cervical disease as women 21 and older, according to the US Food and Drug Administration (FDA). The risk was proven during a pivotal clinical trial of Guided Therapeutics' LightTouch Cervical Scanner, which showed that cervical disea

By cms admin

Women aged 16–20 are just as likely to develop cervical disease as women 21 and older, according to the US Food and Drug Administration (FDA).

The risk was proven during a pivotal clinical trial of Guided Therapeutics’ LightTouch Cervical Scanner, which showed that cervical disease is a significant problem across a large group of the population.

18% of the 290 adolescents presented showed significant disease, the same as the group of 1,317 women aged 21 and older who were correctly identified using LightTouch as having cervical disease.

The study included 1,607 women who received the LightTouch test and other tests routinely used to refer women to biopsy.

290 women between the ages of 16 and 20 were tested, 52 of whom were found to have precancer and cancer missed by the diagnostic standard of care consisting of Pap test, HPV test, colposcopy and biopsy.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management